Novel Designs of Early Phase Trials for Cancer Therapeutics

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Science & Nature, Technology, Engineering
Cover of the book Novel Designs of Early Phase Trials for Cancer Therapeutics by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780128125700
Publisher: Elsevier Science Publication: May 22, 2018
Imprint: Academic Press Language: English
Author:
ISBN: 9780128125700
Publisher: Elsevier Science
Publication: May 22, 2018
Imprint: Academic Press
Language: English

Novel Designs of Early Phase Trials for Cancer Therapeutics provides a comprehensive review by leaders in the field of the process of drug development, the integration of molecular profiling, the changes in early phase trial designs, and endpoints to optimally develop a new generation of cancer therapeutics. The book discusses topics such as statistical perspectives on cohort expansions, the role and application of molecular profiling and how to integrate biomarkers in early phase trials. Additionally, it discusses how to incorporate patient reported outcomes in phase one trials.

This book is a valuable resource for medical oncologists, basic and translational biomedical scientists, and trainees in oncology and pharmacology who are interested in learning how to improve their research by using early phase trials.

  • Brings a comprehensive review and recommendations for new clinical trial designs for modern cancer therapeutics
  • Provides the reader with a better understanding on how to design and implement early phase oncology trials
  • Presents a better and updated understanding of the process of developing new treatments for cancer, the exciting scientific advances and how they are informing drug development
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Novel Designs of Early Phase Trials for Cancer Therapeutics provides a comprehensive review by leaders in the field of the process of drug development, the integration of molecular profiling, the changes in early phase trial designs, and endpoints to optimally develop a new generation of cancer therapeutics. The book discusses topics such as statistical perspectives on cohort expansions, the role and application of molecular profiling and how to integrate biomarkers in early phase trials. Additionally, it discusses how to incorporate patient reported outcomes in phase one trials.

This book is a valuable resource for medical oncologists, basic and translational biomedical scientists, and trainees in oncology and pharmacology who are interested in learning how to improve their research by using early phase trials.

More books from Elsevier Science

Cover of the book Biodiversity of Fungi by
Cover of the book Geology and hydrogeology of carbonate islands by
Cover of the book Medicinal Plants by
Cover of the book High Temperature Superconductors (HTS) for Energy Applications by
Cover of the book Mems for Automotive and Aerospace Applications by
Cover of the book Annual Reports on NMR Spectroscopy by
Cover of the book Human Modeling for Bio-Inspired Robotics by
Cover of the book Advances in Imaging and Electron Physics by
Cover of the book Transition Metal Catalyzed Pyrimidine, Pyrazine, Pyridazine and Triazine Synthesis by
Cover of the book Solar Energy Forecasting and Resource Assessment by
Cover of the book Explosion Hazards in the Process Industries by
Cover of the book Laboratory Methods in Enzymology: Protein Part B by
Cover of the book Energy Conservation in Buildings by
Cover of the book ANSYS Mechanical APDL for Finite Element Analysis by
Cover of the book Systems Evolutionary Biology by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy